Search

Your search keyword '"Takeshi Hisamatsu"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Takeshi Hisamatsu" Remove constraint Author: "Takeshi Hisamatsu" Topic humans Remove constraint Topic: humans
19 results on '"Takeshi Hisamatsu"'

Search Results

1. Proangiogenic effects of MSMP in ovarian cancer

2. Role of ADP receptors on platelets in the growth of ovarian cancer

3. The significance of lymphatic space invasion and its association with vascular endothelial growth factor-C expression in ovarian cancer

4. Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma

5. Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary

6. Efficacy of Raloxifene Hydrochloride for the Prevention of Health Care Problems in Patients Who Undergo Surgery for Endometrial Cancer: A Multicenter Randomized Clinical Trial

7. Combination Treatment With Trabectedin and Irinotecan or Topotecan Has Synergistic Effects Against Ovarian Clear Cell Carcinoma Cells

8. Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers

9. Post-treatment follow-up procedures in cervical cancer patients previously treated with radiotherapy

10. The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the Ovary

11. Targeting mTOR Signaling Pathway in Ovarian Cancer

12. XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A

13. Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study

14. Therapeutic Silencing of KRAS using Systemically Delivered siRNAs

15. Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant feature

16. Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary

17. Elevated white blood cell count at the time of recurrence diagnosis is an indicator of short survival in patients with recurrent cervical cancer

18. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression

19. Prediction of progression-free survival and response to paclitaxel plus carboplatin in patients with recurrent or advanced cervical cancer

Catalog

Books, media, physical & digital resources